Authors:
Gilbert, RE
Akdeniz, A
Allen, TJ
Jerums, G
Citation: Re. Gilbert et al., Urinary transforming growth factor-beta in patients with diabetic nephropathy: implications for the pathogenesis of tubulointerstitial pathology, NEPH DIAL T, 16(12), 2001, pp. 2442-2443
Authors:
Jerums, G
Allen, TJ
Campbell, DJ
Cooper, ME
Gilbert, RE
Hammond, JJ
Raffaele, J
Tsalamandris, C
Citation: G. Jerums et al., Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria, AM J KIDNEY, 37(5), 2001, pp. 890-899
Authors:
Osicka, TM
Yu, YX
Lee, V
Panagiotopoulos, S
Kemp, BE
Jerums, G
Citation: Tm. Osicka et al., Aminoguanidine and ramipril prevent diabetes-induced increases in protein kinase C activity in glomeruli, retina and mesenteric artery, CLIN SCI, 100(3), 2001, pp. 249-257
Authors:
Jerums, G
Cooper, ME
Gilbert, RE
Atkins, RC
Citation: G. Jerums et al., Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes, MED J AUST, 175(8), 2001, pp. 397-399
Authors:
Shinada, M
Akdeniz, A
Panagiotopoulos, S
Jerums, G
Bach, LA
Citation: M. Shinada et al., Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy, J CLIN END, 85(3), 2000, pp. 1163-1169
Authors:
Osicka, TM
Houlihan, CA
Chan, JG
Jerums, G
Comper, WD
Citation: Tm. Osicka et al., Albuminuria in patients with type 1 diabetes is directly linked to changesin the lysosome-mediated degradation of albumin during renal passage, DIABETES, 49(9), 2000, pp. 1579-1584
Authors:
Osicka, TM
Yu, YX
Panagiotopoulos, S
Clavant, SP
Kiriazis, Z
Pike, RN
Pratt, LM
Russo, LM
Kemp, BE
Comper, WD
Jerums, G
Citation: Tm. Osicka et al., Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C, DIABETES, 49(1), 2000, pp. 87-93
Authors:
Jenkins, MA
Houlihan, C
Ratnaike, S
Jerums, G
Parkin, JD
Citation: Ma. Jenkins et al., Measurement of iohexol by capillary electrophoresis: minimizing practical problems encountered, ANN CLIN BI, 37, 2000, pp. 529-536
Citation: T. Sasahara et al., Effects of insulin therapy and glycemic control on distribution of HDL alpha and pre-beta subfractions in non insulin-dependent diabetic subjects, NUTR MET CA, 9(1), 1999, pp. 19-24
Authors:
Gilbert, RE
Cox, AJ
Kelly, DJ
Wilkinson-Berka, JL
Sage, EH
Jerums, G
Cooper, ME
Citation: Re. Gilbert et al., Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye, CONNECT TIS, 40(4), 1999, pp. 295
Authors:
Youssef, S
Nguyen, DT
Soulis, T
Panagiotopoulos, S
Jerums, G
Cooper, ME
Citation: S. Youssef et al., Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding, KIDNEY INT, 55(3), 1999, pp. 907-916
Authors:
Soulis, T
Sastra, S
Thallas, V
Mortensen, SB
Wilken, M
Clausen, JT
Bjerrum, OJ
Petersen, H
Lau, J
Jerums, G
Boel, E
Cooper, ME
Citation: T. Soulis et al., A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes, DIABETOLOG, 42(4), 1999, pp. 472-479
Authors:
Houlihan, C
Scott, A
Jenkins, M
Parkin, D
Osicka, T
Jerums, G
Citation: C. Houlihan et al., A comparison of the plasma disappearance of iohexol and Tc-99m-DTPA for the measurement of glomerular filtration rate (GFR) in diabetes, AUST NZ J M, 29(5), 1999, pp. 693-700
Citation: G. Jerums, Differences in renal outcomes with ACE inhibitors in type 1 and type 2 diabetic patients: Possible explanations, MIN ELECT M, 24(6), 1998, pp. 423-437